Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Point of Care Molecular Diagnostics Market, by Product & Service
1.4.2 Global Point of Care Molecular Diagnostics Market, by End User
1.4.3 Global Point of Care Molecular Diagnostics Market, by Technology
1.4.4 Global Point of Care Molecular Diagnostics Market, by Application
1.4.5 Global Point of Care Molecular Diagnostics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Global Point of Care Molecular Diagnostics Market by Product & Service
4.1 Global Assays & Kits Market by Region
4.2 Global Instruments & Analyzers Market by Region
4.3 Global Software & Services Market by Region
Chapter 5. Global Point of Care Molecular Diagnostics Market by End User
5.1 Global Physicians Offices Market by Region
5.2 Global Hospitals & ICUs Market by Region
5.3 Global Research Institutes Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Point of Care Molecular Diagnostics Market by Technology
6.1 Global RT-PCR Market by Region
6.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Point of Care Molecular Diagnostics Market by Application
7.1 Global Respiratory Diseases Market by Region
7.2 Global Hospital-acquired Infections Market by Region
7.3 Global Sexually Transmitted Diseases Market by Region
7.4 Global Cancer Market by Region
7.5 Global Hepatitis Market by Region
7.6 Global Gastrointestinal Disorders Market by Region
7.7 Global Others Market by Region
Chapter 8. Global Point of Care Molecular Diagnostics Market by Region
8.1 North America Point of Care Molecular Diagnostics Market
8.1.1 North America Point of Care Molecular Diagnostics Market by Product & Service
8.1.1.1 North America Assays & Kits Market by Country
8.1.1.2 North America Instruments & Analyzers Market by Country
8.1.1.3 North America Software & Services Market by Country
8.1.2 North America Point of Care Molecular Diagnostics Market by End User
8.1.2.1 North America Physicians Offices Market by Country
8.1.2.2 North America Hospitals & ICUs Market by Country
8.1.2.3 North America Research Institutes Market by Country
8.1.2.4 North America Others Market by Country
8.1.3 North America Point of Care Molecular Diagnostics Market by Technology
8.1.3.1 North America RT-PCR Market by Country
8.1.3.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
8.1.3.3 North America Others Market by Country
8.1.4 North America Point of Care Molecular Diagnostics Market by Application
8.1.4.1 North America Respiratory Diseases Market by Country
8.1.4.2 North America Hospital-acquired Infections Market by Country
8.1.4.3 North America Sexually Transmitted Diseases Market by Country
8.1.4.4 North America Cancer Market by Country
8.1.4.5 North America Hepatitis Market by Country
8.1.4.6 North America Gastrointestinal Disorders Market by Country
8.1.4.7 North America Others Market by Country
8.1.5 North America Point of Care Molecular Diagnostics Market by Country
8.1.5.1 US Point of Care Molecular Diagnostics Market
8.1.5.1.1 US Point of Care Molecular Diagnostics Market by Product & Service
8.1.5.1.2 US Point of Care Molecular Diagnostics Market by End User
8.1.5.1.3 US Point of Care Molecular Diagnostics Market by Technology
8.1.5.1.4 US Point of Care Molecular Diagnostics Market by Application
8.1.5.2 Canada Point of Care Molecular Diagnostics Market
8.1.5.2.1 Canada Point of Care Molecular Diagnostics Market by Product & Service
8.1.5.2.2 Canada Point of Care Molecular Diagnostics Market by End User
8.1.5.2.3 Canada Point of Care Molecular Diagnostics Market by Technology
8.1.5.2.4 Canada Point of Care Molecular Diagnostics Market by Application
8.1.5.3 Mexico Point of Care Molecular Diagnostics Market
8.1.5.3.1 Mexico Point of Care Molecular Diagnostics Market by Product & Service
8.1.5.3.2 Mexico Point of Care Molecular Diagnostics Market by End User
8.1.5.3.3 Mexico Point of Care Molecular Diagnostics Market by Technology
8.1.5.3.4 Mexico Point of Care Molecular Diagnostics Market by Application
8.1.5.4 Rest of North America Point of Care Molecular Diagnostics Market
8.1.5.4.1 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service
8.1.5.4.2 Rest of North America Point of Care Molecular Diagnostics Market by End User
8.1.5.4.3 Rest of North America Point of Care Molecular Diagnostics Market by Technology
8.1.5.4.4 Rest of North America Point of Care Molecular Diagnostics Market by Application
8.2 Europe Point of Care Molecular Diagnostics Market
8.2.1 Europe Point of Care Molecular Diagnostics Market by Product & Service
8.2.1.1 Europe Assays & Kits Market by Country
8.2.1.2 Europe Instruments & Analyzers Market by Country
8.2.1.3 Europe Software & Services Market by Country
8.2.2 Europe Point of Care Molecular Diagnostics Market by End User
8.2.2.1 Europe Physicians Offices Market by Country
8.2.2.2 Europe Hospitals & ICUs Market by Country
8.2.2.3 Europe Research Institutes Market by Country
8.2.2.4 Europe Others Market by Country
8.2.3 Europe Point of Care Molecular Diagnostics Market by Technology
8.2.3.1 Europe RT-PCR Market by Country
8.2.3.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
8.2.3.3 Europe Others Market by Country
8.2.4 Europe Point of Care Molecular Diagnostics Market by Application
8.2.4.1 Europe Respiratory Diseases Market by Country
8.2.4.2 Europe Hospital-acquired Infections Market by Country
8.2.4.3 Europe Sexually Transmitted Diseases Market by Country
8.2.4.4 Europe Cancer Market by Country
8.2.4.5 Europe Hepatitis Market by Country
8.2.4.6 Europe Gastrointestinal Disorders Market by Country
8.2.4.7 Europe Others Market by Country
8.2.5 Europe Point of Care Molecular Diagnostics Market by Country
8.2.5.1 Germany Point of Care Molecular Diagnostics Market
8.2.5.1.1 Germany Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.1.2 Germany Point of Care Molecular Diagnostics Market by End User
8.2.5.1.3 Germany Point of Care Molecular Diagnostics Market by Technology
8.2.5.1.4 Germany Point of Care Molecular Diagnostics Market by Application
8.2.5.2 UK Point of Care Molecular Diagnostics Market
8.2.5.2.1 UK Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.2.2 UK Point of Care Molecular Diagnostics Market by End User
8.2.5.2.3 UK Point of Care Molecular Diagnostics Market by Technology
8.2.5.2.4 UK Point of Care Molecular Diagnostics Market by Application
8.2.5.3 France Point of Care Molecular Diagnostics Market
8.2.5.3.1 France Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.3.2 France Point of Care Molecular Diagnostics Market by End User
8.2.5.3.3 France Point of Care Molecular Diagnostics Market by Technology
8.2.5.3.4 France Point of Care Molecular Diagnostics Market by Application
8.2.5.4 Russia Point of Care Molecular Diagnostics Market
8.2.5.4.1 Russia Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.4.2 Russia Point of Care Molecular Diagnostics Market by End User
8.2.5.4.3 Russia Point of Care Molecular Diagnostics Market by Technology
8.2.5.4.4 Russia Point of Care Molecular Diagnostics Market by Application
8.2.5.5 Spain Point of Care Molecular Diagnostics Market
8.2.5.5.1 Spain Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.5.2 Spain Point of Care Molecular Diagnostics Market by End User
8.2.5.5.3 Spain Point of Care Molecular Diagnostics Market by Technology
8.2.5.5.4 Spain Point of Care Molecular Diagnostics Market by Application
8.2.5.6 Italy Point of Care Molecular Diagnostics Market
8.2.5.6.1 Italy Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.6.2 Italy Point of Care Molecular Diagnostics Market by End User
8.2.5.6.3 Italy Point of Care Molecular Diagnostics Market by Technology
8.2.5.6.4 Italy Point of Care Molecular Diagnostics Market by Application
8.2.5.7 Rest of Europe Point of Care Molecular Diagnostics Market
8.2.5.7.1 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service
8.2.5.7.2 Rest of Europe Point of Care Molecular Diagnostics Market by End User
8.2.5.7.3 Rest of Europe Point of Care Molecular Diagnostics Market by Technology
8.2.5.7.4 Rest of Europe Point of Care Molecular Diagnostics Market by Application
8.3 Asia Pacific Point of Care Molecular Diagnostics Market
8.3.1 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
8.3.1.1 Asia Pacific Assays & Kits Market by Country
8.3.1.2 Asia Pacific Instruments & Analyzers Market by Country
8.3.1.3 Asia Pacific Software & Services Market by Country
8.3.2 Asia Pacific Point of Care Molecular Diagnostics Market by End User
8.3.2.1 Asia Pacific Physicians Offices Market by Country
8.3.2.2 Asia Pacific Hospitals & ICUs Market by Country
8.3.2.3 Asia Pacific Research Institutes Market by Country
8.3.2.4 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Point of Care Molecular Diagnostics Market by Technology
8.3.3.1 Asia Pacific RT-PCR Market by Country
8.3.3.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
8.3.3.3 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Point of Care Molecular Diagnostics Market by Application
8.3.4.1 Asia Pacific Respiratory Diseases Market by Country
8.3.4.2 Asia Pacific Hospital-acquired Infections Market by Country
8.3.4.3 Asia Pacific Sexually Transmitted Diseases Market by Country
8.3.4.4 Asia Pacific Cancer Market by Country
8.3.4.5 Asia Pacific Hepatitis Market by Country
8.3.4.6 Asia Pacific Gastrointestinal Disorders Market by Country
8.3.4.7 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Point of Care Molecular Diagnostics Market by Country
8.3.5.1 China Point of Care Molecular Diagnostics Market
8.3.5.1.1 China Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.1.2 China Point of Care Molecular Diagnostics Market by End User
8.3.5.1.3 China Point of Care Molecular Diagnostics Market by Technology
8.3.5.1.4 China Point of Care Molecular Diagnostics Market by Application
8.3.5.2 Japan Point of Care Molecular Diagnostics Market
8.3.5.2.1 Japan Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.2.2 Japan Point of Care Molecular Diagnostics Market by End User
8.3.5.2.3 Japan Point of Care Molecular Diagnostics Market by Technology
8.3.5.2.4 Japan Point of Care Molecular Diagnostics Market by Application
8.3.5.3 India Point of Care Molecular Diagnostics Market
8.3.5.3.1 India Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.3.2 India Point of Care Molecular Diagnostics Market by End User
8.3.5.3.3 India Point of Care Molecular Diagnostics Market by Technology
8.3.5.3.4 India Point of Care Molecular Diagnostics Market by Application
8.3.5.4 South Korea Point of Care Molecular Diagnostics Market
8.3.5.4.1 South Korea Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.4.2 South Korea Point of Care Molecular Diagnostics Market by End User
8.3.5.4.3 South Korea Point of Care Molecular Diagnostics Market by Technology
8.3.5.4.4 South Korea Point of Care Molecular Diagnostics Market by Application
8.3.5.5 Singapore Point of Care Molecular Diagnostics Market
8.3.5.5.1 Singapore Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.5.2 Singapore Point of Care Molecular Diagnostics Market by End User
8.3.5.5.3 Singapore Point of Care Molecular Diagnostics Market by Technology
8.3.5.5.4 Singapore Point of Care Molecular Diagnostics Market by Application
8.3.5.6 Malaysia Point of Care Molecular Diagnostics Market
8.3.5.6.1 Malaysia Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.6.2 Malaysia Point of Care Molecular Diagnostics Market by End User
8.3.5.6.3 Malaysia Point of Care Molecular Diagnostics Market by Technology
8.3.5.6.4 Malaysia Point of Care Molecular Diagnostics Market by Application
8.3.5.7 Rest of Asia Pacific Point of Care Molecular Diagnostics Market
8.3.5.7.1 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
8.3.5.7.2 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User
8.3.5.7.3 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology
8.3.5.7.4 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application
8.4 LAMEA Point of Care Molecular Diagnostics Market
8.4.1 LAMEA Point of Care Molecular Diagnostics Market by Product & Service
8.4.1.1 LAMEA Assays & Kits Market by Country
8.4.1.2 LAMEA Instruments & Analyzers Market by Country
8.4.1.3 LAMEA Software & Services Market by Country
8.4.2 LAMEA Point of Care Molecular Diagnostics Market by End User
8.4.2.1 LAMEA Physicians Offices Market by Country
8.4.2.2 LAMEA Hospitals & ICUs Market by Country
8.4.2.3 LAMEA Research Institutes Market by Country
8.4.2.4 LAMEA Others Market by Country
8.4.3 LAMEA Point of Care Molecular Diagnostics Market by Technology
8.4.3.1 LAMEA RT-PCR Market by Country
8.4.3.2 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
8.4.3.3 LAMEA Others Market by Country
8.4.4 LAMEA Point of Care Molecular Diagnostics Market by Application
8.4.4.1 LAMEA Respiratory Diseases Market by Country
8.4.4.2 LAMEA Hospital-acquired Infections Market by Country
8.4.4.3 LAMEA Sexually Transmitted Diseases Market by Country
8.4.4.4 LAMEA Cancer Market by Country
8.4.4.5 LAMEA Hepatitis Market by Country
8.4.4.6 LAMEA Gastrointestinal Disorders Market by Country
8.4.4.7 LAMEA Others Market by Country
8.4.5 LAMEA Point of Care Molecular Diagnostics Market by Country
8.4.5.1 Brazil Point of Care Molecular Diagnostics Market
8.4.5.1.1 Brazil Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.1.2 Brazil Point of Care Molecular Diagnostics Market by End User
8.4.5.1.3 Brazil Point of Care Molecular Diagnostics Market by Technology
8.4.5.1.4 Brazil Point of Care Molecular Diagnostics Market by Application
8.4.5.2 Argentina Point of Care Molecular Diagnostics Market
8.4.5.2.1 Argentina Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.2.2 Argentina Point of Care Molecular Diagnostics Market by End User
8.4.5.2.3 Argentina Point of Care Molecular Diagnostics Market by Technology
8.4.5.2.4 Argentina Point of Care Molecular Diagnostics Market by Application
8.4.5.3 UAE Point of Care Molecular Diagnostics Market
8.4.5.3.1 UAE Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.3.2 UAE Point of Care Molecular Diagnostics Market by End User
8.4.5.3.3 UAE Point of Care Molecular Diagnostics Market by Technology
8.4.5.3.4 UAE Point of Care Molecular Diagnostics Market by Application
8.4.5.4 Saudi Arabia Point of Care Molecular Diagnostics Market
8.4.5.4.1 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.4.2 Saudi Arabia Point of Care Molecular Diagnostics Market by End User
8.4.5.4.3 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology
8.4.5.4.4 Saudi Arabia Point of Care Molecular Diagnostics Market by Application
8.4.5.5 South Africa Point of Care Molecular Diagnostics Market
8.4.5.5.1 South Africa Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.5.2 South Africa Point of Care Molecular Diagnostics Market by End User
8.4.5.5.3 South Africa Point of Care Molecular Diagnostics Market by Technology
8.4.5.5.4 South Africa Point of Care Molecular Diagnostics Market by Application
8.4.5.6 Nigeria Point of Care Molecular Diagnostics Market
8.4.5.6.1 Nigeria Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.6.2 Nigeria Point of Care Molecular Diagnostics Market by End User
8.4.5.6.3 Nigeria Point of Care Molecular Diagnostics Market by Technology
8.4.5.6.4 Nigeria Point of Care Molecular Diagnostics Market by Application
8.4.5.7 Rest of LAMEA Point of Care Molecular Diagnostics Market
8.4.5.7.1 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service
8.4.5.7.2 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User
8.4.5.7.3 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology
8.4.5.7.4 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
9.10.1 Company Overview
Unique Offerings 